Article thumbnail

By Hee-sun Park, Kyung-mi Kim, Kyoung-woon Joung, In-cheol Choi and Ji-yeon Sim

Abstract

Percutaneous trans-catheter aortic valve implantation (TAVI) is recommended for inoperable patients with severe aortic stenosis at high risk for conventional aortic valve replacement. Originally, TAVI was mostly performed under general anesthesia. Here we describe two cases of transfemoral TAVI performed under monitored anesthesia care (MAC) with dexmedetomidine. Dexmedetomidine provides sedation, analgesia with minimal respiratory depression. Although MAC during transfemoral TAVI has limitations, such as unexpected patient movement and difficulty in intra-procedural use of transesophageal echocardiography, MAC with dexmedetomidine is feasible with close monitoring, fluoroscopic guidance and the participation of experienced anesthesiologists. (Korean J Anesthesiol 2014; 66: 317-321) Key Words: Anesthesia, Dexmedetomidine, Heart valve prosthesis implantation, Hypnotics and Sedatives. Monitored anesthesia care with dexmedetomidine in transfemoral percutaneous trans-catheter aortic valve implantation-two cases report

Year: 2016
OAI identifier: oai:CiteSeerX.psu:10.1.1.778.5389
Provided by: CiteSeerX
Download PDF:
Sorry, we are unable to provide the full text but you may find it at the following location(s):
  • ftp://ftp.ncbi.nlm.nih.gov/pub... (external link)
  • ftp://ftp.ncbi.nlm.nih.gov/pub... (external link)
  • http://citeseerx.ist.psu.edu/v... (external link)

  • To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.

    Suggested articles